Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
Julphar
Accenture
Cipla
Chubb

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 10,167,342

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,167,342
Title:Production of hersintuzumab: a new humanized antibody against HER2 for cancer treatment
Abstract: A monoclonal anti-HER2 antibody is mutated on complementarity determining regions (CDRs) and framework regions. The VH domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 1. The VL domain of the antibody includes a portion of the amino acid sequence as SEQ ID NO: 5.
Inventor(s): Shokri; Fazel (Tehran, IR), Jeddi-Tehrani; Mahmood (Tehran, IR), Mehdi Amiri; Mohammad (Tehran, IR)
Assignee:
Application Number:15/249,910
Patent Claims:see list of patent claims

Details for Patent 10,167,342

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Johnson and Johnson
Chinese Patent Office
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.